4.6 Review

Diet and gut microbiome in fatty liver and its associated liver cancer

期刊

出版社

WILEY
DOI: 10.1111/jgh.15713

关键词

diet; gut microbiome; HCC; NASH

资金

  1. National Natural Science Foundation of China [82103355]
  2. RGC Theme-based Research Scheme Hong Kong [T12-703/19R]
  3. Health and Medical Research Fund, Hong Kong [08191336]
  4. CUHK direct grant

向作者/读者索取更多资源

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease worldwide, with the gut microbiome and dietary components playing important roles in its development and its related hepatocellular carcinoma (HCC). Components in the diet such as cholesterol, fiber, fat, and sugar can alter the gut microbiome composition, consequently affecting the progression of NAFLD and related conditions.
Non-alcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease worldwide as a consequence of a sedentary lifestyle and overnutrition. NAFLD could progress to non-alcoholic steatohepatitis (NASH), which may further develop to cirrhosis and hepatocellular carcinoma (HCC). The gut microbiome is one of the central regulators in host metabolism. Diet could change human gut microbiome rapidly and reproducibly and modulate several metabolic pathways. Both diet and gut microbiome dysbiosis are associated with NAFLD and its related HCC (NAFLD-HCC). Dietary cholesterol, fiber, fat, or carbohydrate could change the microbiome composition to contribute to the development of NASH and NAFLD-HCC. Hence, identification of elements of the gut-liver axis that are primarily damaged in NASH and NAFLD-HCC offers new possibility for therapeutic intervention. In this review, the roles of gut microbiome and microbial metabolites in the development and progression of NAFLD and NAFLD-HCC are first discussed. The impacts of different diet compositions including cholesterol, fiber, fat, and sugar on the gut microbiome that leads to predisposition to NASH and NAFLD-HCC are also explored. We summarized the article by discussing potential therapeutic implication of diet and microbiome modulation in fatty liver and liver cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Macrophage p38α promotes nutritional steatohepatitis through M1 polarization

Xiang Zhang, Lina Fan, Jianfeng Wu, Hongzhi Xu, Wing Yan Leung, Kaili Fu, Jingtong Wu, Ken Liu, Kwan Man, Xiaoyong Yang, Jiahuai Han, Jianlin Ren, Jun Yu

JOURNAL OF HEPATOLOGY (2019)

Article Cell Biology

The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and autophagic flux

Xiaoting Chen, Hung Chan, Lin Zhang, Xiaodong Liu, Idy H. T. Ho, Xiang Zhang, Jeffery Ho, Wei Hu, Yuanyuan Tian, Shanglong Kou, Chee Sam Chan, Jun Yu, Sunny H. Wong, Tony Gin, Matthew T. V. Chan, Xuegang Sun, William K. K. Wu

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Oncology

Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer

Tong Li, Beifang Li, Asgharpour Sara, Christine Ay, Wing Yan Leung, Yanquan Zhang, Yujuan Dong, Qiaoyi Liang, Xiang Zhang, Philip Weidner, Tobias Gutting, Hans-Michael Behrens, Christoph Roecken, Joseph J. Y. Sung, Matthias P. Ebert, Jun Yu, Elke Burgermeister

ONCOIMMUNOLOGY (2019)

Article Medicine, General & Internal

Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3

Jing Zhang, Jun-Zhe Huang, Yan-Quan Zhang, Xiang Zhang, Liu-Yang Zhao, Chuan-Gen Li, Yun-Fei Zhou, Hong Wei, Jun Yu

EBIOMEDICINE (2020)

Article Microbiology

Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease

Zhangran Chen, Yurou Xie, Fei Zhou, Bangzhou Zhang, Jingtong Wu, Luxi Yang, Shuangbin Xu, Robert Stedtfeld, Qiongyun Chen, Jingjing Liu, Xiang Zhang, Hongzhi Xu, Jianlin Ren

FRONTIERS IN MICROBIOLOGY (2020)

Article Gastroenterology & Hepatology

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites

Xiang Zhang, Olabisi Oluwabukola Coker, Eagle Sh Chu, Kaili Fu, Harry C. H. Lau, Yi-Xiang Wang, Anthony W. H. Chan, Hong Wei, Xiaoyong Yang, Joseph J. Y. Sung, Jun Yu

Summary: High dietary cholesterol leads to sequential progression of steatosis, steatohepatitis, fibrosis and eventually HCC in mice, concomitant with insulin resistance. Cholesterol-induced NAFLD-HCC formation is associated with gut microbiota dysbiosis, with specific bacterial composition changes between stages of liver disease. Alterations in gut bacterial metabolites were also observed with dietary cholesterol intake. Therapies targeting cholesterol and gut microbiota may be effective for preventing NAFLD-HCC.
Correction Gastroenterology & Hepatology

Macrophage p38 alpha promotes nutritional steatohepatitis through M1 polarization (vol 71, pg 163, 2019)

Xiang Zhang, Lina Fan, Jianfeng Wu, Hongzhi Xu, Wing Yan Leung, Kaili Fu, Jingtong Wu, Ken Liu, Kwan Man, Xiaoyong Yang, Jiahuai Han, Jianlin Ren, Jun Yu

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis

Weixin Liu, Xiang Zhang, Hongzhi Xu, Shengmian Li, Harry Cheuk-Hay Lau, Qiongyun Chen, Bin Zhang, Liuyang Zhao, Huarong Chen, Joseph Jao-Yiu Sung, Jun Yu

Summary: The study revealed that the microbial communities within colorectal neoplasia are heterogeneous, with variations in abundance of CRC-associated pathobionts playing a role in CRC development. Intra-neoplasia changes in microbial abundance were observed along the adenoma-carcinoma sequence. Furthermore, significant differences in intra-neoplasia microbiota were found between biopsies with and without genetic alterations, highlighting the association of intratumoral microbial heterogeneity with genetic changes.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma

Jinkai Liu, Wei Geng, Hanyong Sun, Changan Liu, Fan Huang, Jie Cao, Lei Xia, Hongchuan Zhao, Jianning Zhai, Qing Li, Xiang Zhang, Ming Kuang, Shunli Shen, Qiang Xia, Vincent Wai-Sun Wong, Jun Yu

Summary: The study conducted integrative metabolomics analysis on the altered metabolites in HCC patients, revealing distinct clusters of metabolites in serum, liver tissue, and stool samples that differed significantly from healthy controls. Elevated and depleted metabolites identified in portal vein samples may play a role in HCC development. Linoleic acid and phenol were found to inhibit HCC proliferation, suggesting their potential as protective metabolites.
Review Medicine, General & Internal

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease

Juqiang Han, Xiang Zhang

Summary: NAFLD, including NASH, is a prevalent cause of chronic liver disease worldwide, with potential for severe outcomes like cirrhosis and hepatocellular carcinoma. The complement system, particularly the protein C3, has been identified as playing a crucial role in the pathogenesis of NAFLD, offering new insights for diagnosis and treatment.

FRONTIERS IN MEDICINE (2021)

Article Biochemistry & Molecular Biology

The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC

Qian Song, Xiang Zhang

Summary: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease worldwide due to obesity and metabolic syndrome. Dysbiosis of the gut microbiome and metabolomic changes play a crucial role in the initiation and progression of NAFLD through the gut-liver axis.

BIOMEDICINES (2022)

Article Gastroenterology & Hepatology

Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis

Chuangen Li, Yong Wang, Dabin Liu, Chi Chun Wong, Olabisi Oluwabukola Coker, Xiang Zhang, Changan Liu, Yunfei Zhou, Yali Liu, Wei Kang, Ka Fai To, Joseph J. Y. Sung, Jun Yu

Summary: This study reveals that SQLE plays an oncogenic role in colorectal cancer through both cell intrinsic effects and modulation of the gut microbiota-metabolite axis. SQLE can be a potential therapeutic target and prognostic marker for colorectal cancer.
Review Biochemistry & Molecular Biology

Mouse Models for Application in Colorectal Cancer: Understanding the Pathogenesis and Relevance to the Human Condition

Chuangen Li, Harry Cheuk-Hay Lau, Xiang Zhang, Jun Yu

Summary: This review explores the overall features and mechanisms of carcinogen-induced and transgenic mouse models for colon tumorigenesis, as well as their limitations and applications in evaluating and studying drugs and treatment regimens against CRC. These mouse models provide a better understanding of the mechanisms of colon tumorigenesis and facilitate the discovery of novel therapeutic strategies against CRC.

BIOMEDICINES (2022)

暂无数据